Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00238_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00238_DB01072 label "DDI between Nevirapine and Atazanavir - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atazanavir by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of atazanavir if nevirapine is initiated, discontinued or dose changed. [drugbank_resource:DB00238_DB01072]" assertion.
- drugbank_resource:DB00238_DB01072 identifier "drugbank_resource:DB00238_DB01072" assertion.
- drugbank_resource:DB00238_DB01072 title "DDI between Nevirapine and Atazanavir - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atazanavir by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of atazanavir if nevirapine is initiated, discontinued or dose changed." assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00238_DB01072 assertion.
- drugbank:DB00238 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00238_DB01072 assertion.